Double blind comparison of short and medium term sulfonamides, sulfamethizole and sulfamethoxazole, in uncomplicated acute urinary tract infections.
Sulfamethizole and sulfamethoxazole were compared in a prospective, randomized, double blind study on uncomplicated, acute urinary tract infections. 59 patients were evaluable for therapeutic effect of sulfamethizole and 53 for sulfamethoxazole. The cure rates were 91.5 and 92.5% respectively for sulfamethizole and sulfamethoxazole. The rates of side effects were the same in the two groups, 5.4% and 4.2%. Also instances where the infecting bacteria were sulfonamide-resistant were cured.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011897:Random Allocation; D013419:Sulfamethizole / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013432:Sulfathiazoles / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D013432:Sulfathiazoles; D013419:Sulfamethizole; D013420:Sulfamethoxazole